======= AGBL1 ======= == Gene Information == * **Official Symbol**: AGBL1 * **Official Name**: ATP/GTP binding protein like 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=123624|123624]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96MI9|Q96MI9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AGBL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGBL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615496|Open OMIM]] == Function Summary == * **Entrez Summary**: Polyglutamylation is a reversible posttranslational modification catalyzed by polyglutamylases that results in the addition of glutamate side chains on the modified protein. This gene encodes a glutamate decarboxylase that catalyzes the deglutamylation of polyglutamylated proteins. Mutations in this gene result in dominant late-onset Fuchs corneal dystrophy. [provided by RefSeq, Nov 2013]. * **UniProt Summary**: Metallocarboxypeptidase that mediates deglutamylation of target proteins. Catalyzes the deglutamylation of polyglutamate side chains generated by post-translational polyglutamylation in proteins such as tubulins. Also removes gene-encoded polyglutamates from the carboxy-terminus of target proteins such as MYLK. Acts as a long-chain deglutamylase and specifically shortens long polyglutamate chains, while it is not able to remove the branching point glutamate, a process catalyzed by AGBL5/CCP5. {ECO:0000250|UniProtKB:Q09M05}. |Peptidase M14| |protein side chain deglutamylation| |C-terminal protein deglutamylation| |protein deglutamylation| |C-terminal protein amino acid modification| |metallocarboxypeptidase activity| |peptidyl-glutamic acid modification| |tubulin binding| |post-translational protein modification| |zinc ion binding| |peptidyl-amino acid modification| |proteolysis| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp502|Milciclib 2μM R08 exp502]]|-2.19| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|1.7| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|1.74| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.87| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|2.05| |[[:results:exp131|L-74142 5μM R03 exp131]]|2.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4031 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}